Core Viewpoint - Sugar prices have increased due to a rally in the Brazilian real, which has led to short covering in sugar futures, while higher production in Brazil and India, along with a projected global sugar surplus, are expected to exert downward pressure on prices. Group 1: Sugar Price Movements - March NY world sugar 11 closed up +0.22 (+1.49%) and March London ICE white sugar 5 closed up +4.80 (+1.14%) [1] - The rally in the Brazilian real to a 2.25-month high against the dollar has prompted short covering in sugar futures, discouraging export sales from Brazil's sugar producers [1] Group 2: Production and Supply Dynamics - Brazil's cumulative 2025-26 Center-South sugar output through December rose by +0.9% year-on-year to 40.222 million metric tons (MMT) [3] - The ratio of cane crushed for sugar in Brazil increased to 50.82% in 2025/26 from 48.16% in 2024/25 [3] - India's sugar output from October 1 to January 15 is up +22% year-on-year to 15.9 MMT, with the total production estimate for 2025/26 raised to 31 MMT, up +18.8% year-on-year [5] - The Indian government may permit additional sugar exports to alleviate a domestic supply glut, allowing mills to export 1.5 MMT of sugar in the 2025/26 season [6] Group 3: Global Sugar Surplus Outlook - Covrig Analytics raised its 2025/26 global sugar surplus estimate to 4.7 MMT from 4.1 MMT, but projects a decline to 1.4 MMT in 2026/27 due to weak prices discouraging production [4] - An excessively long position in London ICE white sugar futures could exacerbate any price decline, with funds boosting their net long positions to a record 48,203 [2]

Core Insights - Axsome Therapeutics Inc's stock is experiencing significant gains, rising 19% to $177.13 after the FDA granted priority review for its Alzheimer's disease agitation drug AXS-05 [1] - Analysts from Needham and TD Cowen have reiterated "buy" ratings, with Needham increasing its price target from $154 to $169 [1] - The stock is on track for its largest single-day percentage gain since February, reaching a record peak of $178.99 [2] Stock Performance - If current gains are maintained, Axsome Therapeutics is projected to finish 2025 with over 100% year-to-date gain [2] - The options market has seen a surge, with AXSM's options volume reaching ten times its average daily volume, particularly in the January 2026 185-strike call [2] Short Interest - A portion of the stock's increase may be due to short covering, as short interest accounts for 6.8% of the stock's available float [3] - It would take over five days for short sellers to buy back their borrowed shares based on the stock's average trading pace [3]

Market Reaction to Iran's Attacks - Initial price surge in WTI crude to $7762 was largely due to short covering, as money managers held significant short positions [1][2][5] - If retaliation freezes without infrastructure damage or Strait of Hormuz closure, prices may cool off due to no supply impact and continued OPEC production [3][4][5] - Closure of the Strait of Hormuz would significantly impact prices, increasing shipping costs and transit times, though alternatives like the Suez Canal exist [11][12] US Oil Production and Supply - US shale production may have peaked, with declining rig counts potentially putting downward pressure on oil production [6][8] - Despite potential production pullback, the United States remains one of the largest oil producers globally, maintaining production above 13 million barrels per day [4][8] Economic Factors and Future Outlook - Economic growth, US-China negotiations, and inflation trends influence oil prices [9] - Positive GDP outlook in the second quarter and boosted global GDP forecasts may support oil prices [10] - If the situation stabilizes, the high of $7762 for WTI and $7850 for Brent may be the peak for the remainder of 2025 [10]